Posts Tagged :

Oncology

A Pharmacist’s Oncology Journey 1012 675 Shields Health Solutions

A Pharmacist’s Oncology Journey

Kevin Poel, a Clinical Pharmacist at Shields Health Solutions, was a freshman in college in New Mexico, playing on the soccer team, when he got an unusual call from his…

Excelera® and Aptitude Health Offer New Specialty Pharmacy Focused Educational Resources for Cancer Care 204 115 Shields Health Solutions

Excelera® and Aptitude Health Offer New Specialty Pharmacy Focused Educational Resources for Cancer Care

MINNEAPOLIS–(BUSINESS WIRE)–Excelera®, a wholly-owned subsidiary of Shields Health Solutions and the company behind the Excelera Network, announced today a new specialty pharmacy-focused educational offering in partnership with Aptitude Health, which provides critical insights…

One Survivor’s Story and How She Pays It Forward 1024 576 Shields Health Solutions

One Survivor’s Story and How She Pays It Forward

June 7 marks National Cancer Survivors Day. In today’s Care Corner Blog, we feature one of our own pharmacy liaisons who bravely defeated cancer and now assists those in the Shields…

Making a Difference on a Patients Life and Outlook 1024 576 Shields Health Solutions

Making a Difference on a Patients Life and Outlook

This week’s “Care Corner” story was provided to us by our Director of Support Operations, Angela Killay. As Director of Support Operations, Angela leads our Patient support team in providing…

At-Home Cancer Care, Infusions Widespread Amid Pandemic 150 150 Shields Health Solutions

At-Home Cancer Care, Infusions Widespread Amid Pandemic

Specialty Pharmacy Times, a bi-monthly journal and daily news website serving the business and practice of specialty pharmaceuticals and therapy, has expanded its Strategic Alliance Partnership program with the addition of the Excelera Specialty Pharmacy Network, a unique national network of academic institutions and large integrated delivery systems-based specialty pharmacies providing coordinated care to drive higher quality outcomes with complex patients.
COVID Jump-Starts Cancer Care at Home 150 150 Shields Health Solutions

COVID Jump-Starts Cancer Care at Home

As the COVID-19 pandemic spread across the country and hospitals reduced in-person visits to a bare minimum, health systems—such as Partners Healthcare, M Health Fairview and Northwestern—worked to ensure that…

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center 150 150 Shields Health Solutions

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center

By Martha Stutsky, PharmD, BCPS; and Osama Abdelghany, PharmD, MHA, BCOP Smilow Cancer Hospital at Yale New Haven Health System in Connecticut is 1 of 45 National Cancer Institute–designated comprehensive…

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective 150 150 Shields Health Solutions

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective

By Claudia S. Castro, PharmD, MS, BCOP, BCGP; and Amanda Manoogian, PharmD, BCOP The prevalence of individuals living with cancer continues to rise, largely because of an aging and growing…

COVID & Oncology – The Effects on Health System Specialty Pharmacies 1024 791 Shields Health Solutions

COVID & Oncology – The Effects on Health System Specialty Pharmacies

This blog was written by Excelera, a Shields company. Two months ago, our blog discussed the potential impacts and areas of concern for health system specialty pharmacies and COVID. However,…

Orlando Health Provides Patients with Improved Outcomes Through Increased Access to Innovative Oncology Treatments by Joining the Excelera Network 204 115 Shields Health Solutions

Orlando Health Provides Patients with Improved Outcomes Through Increased Access to Innovative Oncology Treatments by Joining the Excelera Network

Orlando Health is the first health system in Florida to partner with Excelera®, the company behind the Excelera Network, to further optimize its specialty pharmacy services and to provide patients with increased access to limited distribution drugs (LDDs), which include innovative oncology treatments.